Dihydrocodeine
Who holds supplier records for Dihydrocodeine? 4 organisations hold a current record for Dihydrocodeine: an active US FDA Type II Drug Master File or a CEP. 4 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: Slovakia (1) and Hungary (1); not recorded for 2.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Dihydrocodeine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/dihydrocodeine
Reading the evidence
- 4 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 2 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (4)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Dihydrocodeine. Country is the organisation's recorded country, not necessarily the manufacturing site.
- MACFARLAN SMITH LTDCEP Company GMP cert on record
- SALARS SPACEP
- SlovakiaCEP Company GMP cert on record
- ALKALOIDA CHEMICAL COMPANY ZRT. TiszavasvariHungaryCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (4)
Certificates of Suitability on the EDQM register for Dihydrocodeine, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| SANECA PHARMACEUTICALS A.S. Hlohovec | SK | R1-CEP 2008-018 - Rev 01 Dihydrocodeine hydrogen tartrate | Jul 2021 | — |
| ALKALOIDA CHEMICAL COMPANY ZRT. Tiszavasvari | HU | R1-CEP 2009-225 - Rev 02 Dihydrocodeine hydrogen tartrate | Aug 2020 | — |
| MACFARLAN SMITH LIMITED Edinburgh | GB | R1-CEP 2003-209 - Rev 01 Dihydrocodeine hydrogen tartrate | Feb 2015 | — |
| S.A.L.A.R.S. S.p.A. Como | IT | R1-CEP 2004-187 - Rev 01 Dihydrocodeine hydrogen tartrate | Apr 2011 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Overview
Dihydrocodeine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1595).
Chemical identity
- IUPAC name
- (4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,5,6,7,7a,13-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-ol
- Canonical SMILES
- CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](CC4)O
- InChIKey
- RBOXVHNMENFORY-DNJOTXNNSA-N
- Synonyms
- 8,14-dihydroneopine, .alpha.-hydrocodol, Codhydrine, Dehacodin, Dh-codeine, Dihidrocodeina, Dihydrocodeine, IDS-ND-008(SECT.2), Novicondin, NSC-231319, Rapacodin, Remedacen
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Dihydrocodeine?
4 organisations hold an active US FDA Type II Drug Master File or a CEP for Dihydrocodeine: MACFARLAN SMITH LTD, SALARS SPA, SANECA PHARMACEUTICALS AS (Slovakia) and ALKALOIDA CHEMICAL COMPANY ZRT. Tiszavasvari (Hungary). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Does Dihydrocodeine have a European Certificate of Suitability?
Yes. 4 organisations hold a valid CEP for Dihydrocodeine on the EDQM register, including SANECA PHARMACEUTICALS A.S. Hlohovec (SK), ALKALOIDA CHEMICAL COMPANY ZRT. Tiszavasvari (HU), MACFARLAN SMITH LIMITED Edinburgh (GB) and S.A.L.A.R.S. S.p.A. Como (IT). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Dihydrocodeine supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Dihydrocodeine?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.